Michael J. Fox Honored with Medal, Drives Parkinson's Research

The actor's advocacy work and foundation's funding are reshaping the fight against the disease.

Jan. 27, 2026 at 5:55pm by Ben Kaplan

Got story updates? Submit your updates here. ›

Michael J. Fox's recent Presidential Medal of Freedom recognition shines a spotlight on his relentless advocacy work and the $2.5 billion his foundation has poured into Parkinson's research, exceeding federal funding. The field is rapidly shifting towards disease-modifying therapies, genetic research, and the use of biomarkers and technology to advance early detection and treatment.

Why it matters

Fox's high-profile advocacy has helped raise awareness and funding for Parkinson's research, which is critical as the field moves beyond just symptom management towards potential breakthroughs in slowing or reversing the underlying neurodegeneration. His continued engagement with policymakers is also shaping the political landscape around funding and support for this important work.

The details

Parkinson's treatment is evolving beyond just managing symptoms like tremors and slowness of movement. Researchers are now focused on disease-modifying therapies that target proteins like alpha-synuclein, as well as leveraging genetic research and biomarkers for early detection. Technology is also playing a growing role, from digital therapeutics to AI-powered drug discovery. Gene therapy holds promise, while lifestyle factors like exercise and diet are also emerging as important components of a holistic approach.

  • Michael J. Fox was recently awarded the Presidential Medal of Freedom.

The players

Michael J. Fox

An acclaimed actor who has been a tireless advocate for Parkinson's research and awareness since his own diagnosis in 1991.

The Michael J. Fox Foundation

A non-profit organization founded by Michael J. Fox that has invested over $2.5 billion into Parkinson's research, exceeding federal funding.

Dr. Claire Thompson

A neurologist specializing in movement disorders at the University of California, San Francisco.

Robert F. Kennedy Jr.

The newly appointed head of the Department of Health and Human Services, whose stance on stem cell research could impact Parkinson's research.

Got photos? Submit your photos here. ›

What they’re saying

“We're moving beyond a 'one-size-fits-all' approach. Genetic research is revealing that Parkinson's isn't a single disease, but a spectrum of disorders with different underlying causes. This means we need personalized treatments tailored to each patient's genetic profile and disease progression.”

— Dr. Claire Thompson, neurologist specializing in movement disorders

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

Michael J. Fox's advocacy work has been instrumental in driving progress in Parkinson's research, from funding cutting-edge studies to engaging policymakers. As the field evolves towards more personalized, technology-enabled approaches, his continued leadership will be crucial in ensuring that research remains a priority and that patients have access to the latest advancements.